Screening-detected lung cancers: Is systematic nodal dissection always essential?

Journal of Thoracic Oncology

Volumn 6, Issue 3, 2011, Pages 525-530

  Veronesi, Giulia ^a   Maisonneuve, Patrick ^a   Pelosi, Giuseppe ^a   Casiraghi, Monica ^a   Agoglia, Bernardo G ^a   Borri, Alessandro ^a   Travaini, Laura L ^a   Bellomi, Massimo ^a,b   Rampinelli, Cristiano ^a   Brambilla, Daniela ^a   Bertolotti, Raffaella ^a   Spaggiari, Lorenzo ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Fluorodeoxyglucose; Lymph node involvement; NSCLC; Positron emission tomography computed tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG CANCER; LUNG HILUS; LUNG NODULE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 79951767684     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318206dbcc     Document Type: Article

References (30)

1. Henschke CI, Yankelevitz DF, Libby DM, et al. International Early Lung Cancer Action Program Investigators. Survival of patients with stage 1 lung cancer detected on CT screening. N Engl J Med 2006;355: 1763-1771. (Pubitemid 44631359)
2. Veronesi G, Bellomi M, Mulshine, et al. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer 2008;61:340-349.
3. New York Early Lung Cancer Action Project Investigators. CT screening for lung cancer: diagnoses resulting from the New York Early Lung Cancer Action Project. Radiology 2007;243:239-249.
4. Pastorino U, Landoni C, Marchianò A, et al. Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers. J Thorac Oncol 2009;4:1352-1356.
5. Mulshine JL, Sullivan DC. Clinical practice. Lung cancer screening. New Engl J Med 2005;352:2714-2720. (Pubitemid 41007826)
6. Allen MS, Darling GE, Taine TV, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006;81:1013-1020. (Pubitemid 43247678)
7. Rubinstein LV, Ginsberg RJ. Lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1996;62:1249-1250. (Pubitemid 26340377)
8. Landreneau RJ, Sugarbaker DJ, Mack MJ, et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. J Thorac Cardiovasc Surg 1997;113:691-700. (Pubitemid 27167319)
9. Miller DL, Rowland CM, Deschamps C, et al. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg 2002;73:1545-1551. (Pubitemid 34596588)
10. Available at: http://clinicaltrials.gov/ct2/show/NCT00499330. Accessed December 3, 2010.
11. Nonaka M, Kadokura M, Yamamoto S, et al. Tumor dimension and prognosis in surgically treated lung cancer for intentional limited resection tumor dimension and prognosis in surgically treated lung cancer for intentional limited resection. Am J Clin Oncol 2003;26:499-503. (Pubitemid 37248270)
12. Veeramachaneni NK, Battafarano RJ, Meyers BR, et al. Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival. Eur J Cardiothorac Surg 2008;33:466-469.
13. Lardinois D, De Leyn P, Van Schil P, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006;30:787-792. (Pubitemid 44572768)
14. American Thoracic Society. Clinical staging of primary lung cancer. Am Rev Respir Dis 1983;127:659-664.
15. Kramer H, Groen HJM. Current concepts in the mediastinal lymph node staging of non small cell lung cancer. Ann Surg 2003;238:180-188. (Pubitemid 38174491)
16. Izbicki JR, Passlick B, Pantel K, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg 1998;227:138-144. (Pubitemid 28071349)
17. Sugi K, Nawata K, Fujita N, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg 1998;22:290-294.
18. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest 2009;136:260-271.
19. Cerfolio RJ, Ojha B, Bryant AS, et al. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with non-small cell lung cancer. Ann Thorac Surg 2004;78:1017-1023. (Pubitemid 39164825)
20. Park HK, Jeon K, Koh WJ, et al. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT. Respirology 2010;15:1179-1184.
21. Takizawa H, Kondo K, Matsuoka H, et al. Effect of mediastinal lymph nodes sampling in patients with clinical stage I non-small cell lung cancer. J Med Invest 2008;55:37-43. (Pubitemid 351643591)
22. Lee PC, Port JL, Korst RJ, et al. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg 2007;84:177-181. (Pubitemid 46921151)
23. Hsu PK, Huang HC, Hsieh CC, et al. Effect of formalin fixation on tumor size determination in stage I non-small cell lung cancer. Ann Thorac Surg 2007;84:1825-1829.
24. Vesselle H, Schmidt RA, Pugsley JM, et al. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 2000;6:3837-3844.
25. Vesselle H, Freeman JD, Wiens L, et al. Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role. Clin Cancer Res 2007;13:3255-3263. (Pubitemid 46944910)
26. Al-Sarraf N, Aziz R, Gately K, et al. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. Eur J Cardiothorac Surg 2008;33:104-109. (Pubitemid 350266343)
27. Ishida T, Yano T, Maeda K, et al. Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Ann Thorac Surg 1990;50:708-713. (Pubitemid 20367728)
28. Konaka C, Ikeda N, Hiyoshi T, et al. Peripheral non-small cell lung cancers 2.0 cm or less in 290 diameter: proposed criteria for limited pulmonary resection based upon clinicopathological presentation. Lung Cancer 1998;21:185-191. (Pubitemid 28491366)
29. Zhoua Q, Suzuki K, Anami Y, et al. Clinicopathologic features in resected subcentimeter lung cancer-status of lymph node metastases. Interact Cardiovasc Thorac Surg 2010;10:53-57.
30. Nair VS, Barnett PG, Ananth L, et al. Positron emission tomography (PET) 18F-fluorodeoxyglucose (FDG) uptake and prognosis in patients with resected, clinical stage Ia non-small cell lung cancer. Chest 2010; 137:1150-1156.